| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Direct ovarian effects and safety aspects of GnRH agonists and antagonists
|
Tarlatzis, BC
|
|
2002
|
5 |
S1 |
p. 8-13
6 p.
|
article
|
| 2 |
GnRH antagonists: do they open new pathways to safer treatment in assisted reproductive techniques?
|
Olivennes, F
|
|
2002
|
5 |
S1 |
p. 20-25
6 p.
|
article
|
| 3 |
Gonadotrophin-releasing hormone (GnRH) and GnRH agonists: mechanisms of action
|
Ortmann, O
|
|
2002
|
5 |
S1 |
p. 1-7
7 p.
|
article
|
| 4 |
Molecular basis of implantation
|
Pellicer, A
|
|
2002
|
5 |
S1 |
p. 44-51
8 p.
|
article
|
| 5 |
Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix
|
Asimakopoulos, Byron
|
|
2002
|
5 |
S1 |
p. 52-56
5 p.
|
article
|
| 6 |
Ovarian stimulation for IVF and endometrial receptivity – the missing link
|
van der Gaast, MH
|
|
2002
|
5 |
S1 |
p. 36-43
8 p.
|
article
|
| 7 |
Ovarian stimulation: from basic science to clinical application
|
Ludwig, Michael
|
|
2002
|
5 |
S1 |
p. 73-86
14 p.
|
article
|
| 8 |
Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born
|
Ludwig, M
|
|
2002
|
5 |
S1 |
p. 61-67
7 p.
|
article
|
| 9 |
The luteal phase after ovarian stimulation
|
Kolibianakis, Efstratios M
|
|
2002
|
5 |
S1 |
p. 26-35
10 p.
|
article
|
| 10 |
The need for new methods of ovarian stimulation
|
Crosignani, Pier Giorgio
|
|
2002
|
5 |
S1 |
p. 57-60
4 p.
|
article
|
| 11 |
The role of GnRH antagonists in assisted reproduction
|
Barri, Pedro N
|
|
2002
|
5 |
S1 |
p. 14-19
6 p.
|
article
|
| 12 |
Will GnRH antagonists assist in the treatment of benign gynaecological diseases?
|
Felberbaum, Ricardo E
|
|
2002
|
5 |
S1 |
p. 68-72
5 p.
|
article
|
Journal description